PMGC HOLDINGS INC. Operating Lease Cost
PMGC HOLDINGS INC. (ELAB) reported Operating Lease Cost of $119.22 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-11-14
- PMGC HOLDINGS INC. operating lease, cost for the quarter ending 2024-09-30 was $39.74K, a 0.00% change year-over-year.
- PMGC HOLDINGS INC. operating lease, cost for the quarter ending 2024-06-30 was $39.74K, a 25.64% increase year-over-year.
- PMGC HOLDINGS INC. operating lease, cost for the quarter ending 2024-03-31 was $39.74K, a 25.64% increase year-over-year.
- PMGC HOLDINGS INC. operating lease, cost for the quarter ending 2023-12-31 was $39.74K.
- PMGC HOLDINGS INC. operating lease, cost for fiscal 2023 was $142.74K, a 93.41% increase from fiscal 2022.
- PMGC HOLDINGS INC. operating lease, cost for fiscal 2022 was $73.80K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $39.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $79.48K derived: sum of 2 quarters · filed 2024-11-14 | $119.22K 10-Q · filed 2024-11-14 | $158.96K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | $39.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $79.48K 10-Q · filed 2024-08-14 | $119.22K derived: sum of 3 quarters · filed 2024-08-14 | $158.96K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-03-31 | $39.74K 10-Q · filed 2024-05-15 | $79.48K derived: sum of 2 quarters · filed 2024-05-15 | $119.22K derived: sum of 3 quarters · filed 2024-11-14 | $150.85K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-12-31 | $39.74K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $79.48K derived: sum of 2 quarters · filed 2024-11-14 | $111.11K derived: sum of 3 quarters · filed 2024-11-14 | $142.74K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $39.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $71.37K derived: sum of 2 quarters · filed 2024-11-14 | $103.00K 10-Q · filed 2024-11-14 | $103.00M 10-Q · filed 2023-12-11 | -$42.00M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $31.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $63.26K 10-Q · filed 2024-08-14 | -$42.04M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $31.63K 10-Q · filed 2024-05-15 | -$42.07M derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$42.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $73.80K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $42.17M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |